BEAM Stock: Price, Earnings History and SEC Filings
Beam Therapeutics Inc. (BEAM) last traded at $27.23, down 5.58% on the latest session and up 11.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.18 against an analyst estimate of $-1.00, a miss of 18.0%.
$27.23 -5.58%
1 month+11.37%
52-week high$38.26
52-week low$20.23
Volume1.50M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BEAM earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $-1.18 | $-1.00 | -18.00% |
| Mar 2026 | May 7, 2026 | $-0.91 | $-0.87 | -4.60% |
| Dec 2025 | Feb 24, 2026 | $-0.10 | $-1.13 | +91.15% |
| Sep 2025 | Nov 4, 2025 | $-1.10 | $-0.98 | -12.24% |
BEAM beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for BEAM
SEC filing data is not available right now. You can search for BEAM on SEC EDGAR.
BEAM news
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Oct 31, 2026 · stocktwits.com
- 3 Promising Genomics Stocks to Add to Your Portfolio NowOct 30, 2026 · finance.yahoo.com
- Global Gene Writing Technology Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 24.8% CAGR with Beam, Twist Bioscience, Tessera, and IntelliaOct 29, 2026 · finance.yahoo.com
- Monte Rosa Therapeutics (GLUE) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Why Beam Therapeutics Stock Is Up 15.6% And What's NextOct 29, 2026 · finance.yahoo.com
- Beam Therapeutics (BEAM) Moves 15.6% Higher: Will This Strength Last?Oct 29, 2026 · finance.yahoo.com
- BEAM Stock Climbs On First Look At One-Time GSDIa Gene Fix; H.C. Wainwright Sees Further 200% UpsideOct 27, 2026 · stocktwits.com
- Beam Therapeutics Reports Early BEAM-301 Gains in GSD1a Fasting ToleranceOct 27, 2026 · marketbeat.com
About Beam Therapeutics Inc.
Beam Therapeutics Inc. (BEAM) is a US-listed public company on Nasdaq.